Stock Events

Stock Events

Veracyte 

$42.53
94
-$2.14-4.79% Friday 20:00
-$0.87-2.06%Friday 22:39After hours

Statistics

Day High
42.57
Day Low
42.46
52W High
60.91
52W Low
29.46
Volume
35,162
Avg. Volume
-
Mkt Cap
3.42B
P/E Ratio
52.75
Dividend Yield
-
Dividend
-

Upcoming

Earnings

10NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
0.06
0.22
0.38
0.54
Expected EPS
0.409091
Actual EPS
N/A

Financials

12.83%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
517.15MRevenue
66.35MNet Income

Analyst Ratings

55.75Average Price Target
The highest estimate is 69.00.
From 8 ratings within the last 6 months. This is not an investment recommendation.
Buy
75%
Hold
13%
Sell
13%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow VCYT. It's not an investment recommendation.
NVIDIA
24
NVDA
Alphabet
23
GOOGL
Tesla
22
TSLA
Amazon
21
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Guardant Health
GH
Mkt Cap21.67B
Guardant Health offers liquid biopsy tests that compete with Veracyte's genomic diagnostics for cancer.
Illumina
ILMN
Mkt Cap32.55B
Illumina provides genomic sequencing technologies and services that are foundational to the development of tests like those offered by Veracyte.
Fulgent Genetics
FLGT
Mkt Cap539.57M
Fulgent Genetics provides comprehensive genetic testing services, competing in the same space as Veracyte.
Bionano Genomics
BNGO
Mkt Cap13.78M
Bionano Genomics offers genomic analysis tools, competing with Veracyte in the genomic diagnostics market.
Pacific Biosciences of California
PACB
Mkt Cap435.16M
Pacific Biosciences offers sequencing technologies that compete with the genomic analysis and diagnostics provided by Veracyte.
Qiagen NV
QGEN
Mkt Cap8.9B
Qiagen provides sample and assay technologies for molecular diagnostics, competing with Veracyte in the diagnostics market.
Myriad Genetics
MYGN
Mkt Cap302.25M
Myriad Genetics offers genetic testing and personalized medicine, directly competing with Veracyte in the genetic diagnostics market.
Intellia Therapeutics
NTLA
Mkt Cap1.8B
Intellia Therapeutics is involved in CRISPR technology for gene editing, which could compete with Veracyte's genomic diagnostics by offering alternative approaches to understanding and treating diseases.

About

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).
Show more...
CEO
Marc Stapley
Employees
755
Country
United States
ISIN
US92337F1075
WKN
000A1W7EA

Listings

F
DE
12V.F
STU
DE
12V.STU
XNAS
US
VCYT
BOATS
BOATS
VCYT.BOATS

0 Comments

Share your thoughts

FAQ

What is Veracyte stock price today?▼
The current price of VCYT is $42.53 USD — it has decreased by -4.79% in the past 24 hours. Watch Veracyte stock price performance more closely on the chart.
What is Veracyte stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Veracyte stocks are traded under the ticker VCYT.
Is Veracyte stock price growing?▼
VCYT stock has fallen by -1.87% compared to the previous week, the month change is a -7.84% fall, over the last year Veracyte has showed a +31.14% increase.
What is Veracyte market cap?▼
Today Veracyte has the market capitalization of 3.42B
When is the next Veracyte earnings date?▼
Veracyte is going to release the next earnings report on November 10, 2026.
What were Veracyte earnings last quarter?▼
VCYT earnings for the last quarter are 0.54 USD per share, whereas the estimation was 0.41 USD resulting in a +31.62% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Veracyte revenue for the last year?▼
Veracyte revenue for the last year amounts to 517.15M USD.
What is Veracyte net income for the last year?▼
VCYT net income for the last year is 66.35M USD.
How many employees does Veracyte have?▼
As of September 05, 2026, the company has 755 employees.
In which sector is Veracyte located?▼
Veracyte operates in the Health & Wellness sector.
When did Veracyte complete a stock split?▼
Veracyte has not had any recent stock splits.
Where is Veracyte headquartered?▼
Veracyte is headquartered in SOUTH SAN FRANCISCO, United States.